The level of fetuin A can be used to assess the risk of atherosclerosis in a group of patients with CKD, since its levels begin to decline at the onset of the disease and are significantly reduced in patients suffering from atheromatosis [33,34]. The gene discussed is AHSG; the disease is chronic kidney disease.